bromocriptine has been researched along with Local Neoplasm Recurrence in 38 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 15 (39.47) | 18.7374 |
1990's | 11 (28.95) | 18.2507 |
2000's | 5 (13.16) | 29.6817 |
2010's | 4 (10.53) | 24.3611 |
2020's | 3 (7.89) | 2.80 |
Authors | Studies |
---|---|
Dai, C; Guan, S; Kang, J; Li, Y; Liu, H; Sun, B; Wang, W; Zhang, J | 1 |
Chen, S; Dong, J; Gu, J; Jiang, X; Li, D; Wen, X; Zou, Y | 1 |
Li, Z; Liu, Z; Shao, Z; Song, C; Wang, X; Xiao, Z; Yang, X; Zhang, K | 1 |
Bilbao, I; Egaña, N; García, C; Olaizola, I | 1 |
Bai, J; Cao, L; Gao, H; Hong, L; Lan, X; Li, C; Lu, R; Wang, F; Wu, Y; Zhang, Y | 1 |
Couldwell, WT; Eloy, JA; Liu, JK; Wong, A | 1 |
Dogansen, SC; Selcukbiricik, OS; Tanrikulu, S; Yarman, S | 1 |
Chang, JY; Kattah, JC; Orth, EH; Talkad, AV; Xu, MY | 1 |
Adler, I; Barsi, P; Czirják, S; Gergics, P; Jakab, C; Rácz, K; Varga, I | 1 |
Benveniste, RJ; Delman, BN; King, WA; Lee, JS; Post, KD; Walsh, J | 1 |
Abouzari, M; Aghazadeh, J; Hazrati, SM; Mohtarami, F; Rashidi, A | 1 |
Kauppila, A | 1 |
Thomas, JP | 1 |
Kahn, SE; Miller, JL | 1 |
Frick, J; Galvan, G; Irnberger, T | 1 |
Hall, K; Hall, R; Johnston, DG; Kendall-Taylor, P; McGregor, A; Ross, WM | 1 |
Bergstralh, EJ; Groover, RV; Horvath, E; Kane, LA; Kovacs, K; Laws, ER; Leinung, MC; Scheithauer, BW; Zimmerman, D | 1 |
Duthel, R; Estour, B; Malluret, J; Rachidi-Koussa, H; Vergely, N | 1 |
Blohmer, JU; Bollmann, R; Chaoui, R; Kürten, A; Lau, HU | 1 |
Burkert, W; Rainov, NG | 1 |
Downey, DE; Feigenbaum, SL; Jaffe, RB; Wilson, CB | 1 |
Molitch, ME; Thorner, MO; Wilson, C | 1 |
Bácsy, E; Czirják, S; Fazekas, I; Pásztor, E; Slowik, F | 1 |
Handa, J; Nakasu, S; Nakasu, Y; Shiino, A | 1 |
Alatli, C; Aydin, Y; Can, SM; Gŭlkilik, A; Tŭrkmenoglu, O; Ziyal, I | 1 |
Agostini, S; Billeci, D; Conte, N; De Menis, E; Marton, E; Tramontin, P; Visentin, A | 1 |
Fellmann, H; Landolt, AM; Wüthrich, R | 1 |
MacFarlane, IA; MacKenzie, JM; Petterson, T; Shaw, MD | 1 |
DeMichele, D; Di Chiro, G; Francavilla, TL; Miletich, RS; Oldfield, EH; Patronas, NJ; Weintraub, BD | 1 |
Bots, GT; Luyendijk, W; van Dulken, H; van Seters, AP; Vielvoye, GJ | 1 |
Fode, NC; Laws, ER; Redmond, MJ | 1 |
Barrow, DL; Mizuno, J; Tindall, GT | 1 |
Muraszko, K; Post, KD | 1 |
Beck, W; Stubbe, P | 1 |
Klem, V; Praest, J | 1 |
Bendsen, BB; Wollesen, F | 1 |
Gauer, J; Heberling, HJ; Lohmann, D; Richardt, W; Stubert, B | 1 |
De Gennes, JL; Heshmati, HM; Metzger, J; Schaison-Cusin, M; Scherrer, H; Thibierge, M; Turpin, G | 1 |
7 review(s) available for bromocriptine and Local Neoplasm Recurrence
Article | Year |
---|---|
Evolution of a refractory prolactin-secreting pituitary adenoma into a pituitary carcinoma: report of a challenging case and literature review.
Topics: Adult; Bromocriptine; Carcinoma; Craniotomy; Disease Progression; Female; Hormone Antagonists; Humans; Neoplasm Recurrence, Local; Neurosurgical Procedures; Pituitary Neoplasms; Prolactinoma; Radiosurgery; Reoperation; Spinal Cord Neoplasms | 2021 |
The recurrence of prolactinoma after withdrawal of dopamine agonist: a systematic review and meta-analysis.
Topics: Bromocriptine; Cabergoline; Deprescriptions; Dopamine Agonists; Humans; Neoplasm Recurrence, Local; Pituitary Neoplasms; Prolactinoma | 2021 |
Update on prolactinomas. Part 2: Treatment and management strategies.
Topics: Bromocriptine; Cabergoline; Disease Management; Dopamine Agonists; Drug Administration Schedule; Drug Resistance, Neoplasm; Ergolines; Female; Humans; Hyperprolactinemia; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Neuroendoscopy; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactin; Prolactinoma; Radiosurgery; Sphenoid Sinus | 2015 |
Progestin therapy of endometrial, breast and ovarian carcinoma. A review of clinical observations.
Topics: Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Bromocriptine; Dose-Response Relationship, Drug; Estrogen Antagonists; Female; Forecasting; Humans; Hydroxyprogesterones; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Neoplasm Recurrence, Local; Ovarian Neoplasms; Progestins; Receptors, Steroid; Uterine Neoplasms | 1984 |
Treatment of acromegaly.
Topics: Acromegaly; Adenoma; Bromocriptine; Growth Hormone; Humans; Methods; Neoplasm Recurrence, Local; Pituitary Irradiation; Pituitary Neoplasms | 1983 |
Management of pituitary tumors.
Topics: Acromegaly; Adenoma; Bromocriptine; Cushing Syndrome; Humans; Nelson Syndrome; Neoplasm Recurrence, Local; Pituitary Neoplasms; Prolactin | 1986 |
Effect rates of different modalities for treatment of prolactin adenomas.
Topics: Adenoma; Adult; Bromocriptine; Combined Modality Therapy; Evaluation Studies as Topic; Female; Humans; Male; Neoplasm Recurrence, Local; Pituitary Function Tests; Pituitary Neoplasms; Prolactin | 1985 |
31 other study(ies) available for bromocriptine and Local Neoplasm Recurrence
Article | Year |
---|---|
Estrogen receptor α/prolactin receptor bilateral crosstalk promotes bromocriptine resistance in prolactinomas.
Topics: Adolescent; Adult; Animals; Antineoplastic Combined Chemotherapy Protocols; Bromocriptine; Cell Line, Tumor; Cyclin D1; Drug Resistance, Neoplasm; Estradiol; Estrogen Receptor alpha; Female; Fulvestrant; Humans; Hypophysectomy; Male; MAP Kinase Signaling System; Middle Aged; Neoplasm Recurrence, Local; Pituitary Gland; Pituitary Neoplasms; Prolactin; Prolactinoma; Rats; Receptors, Prolactin; Young Adult | 2020 |
Failure of a second temozolomide cycle in a patient with a prolactin-secreting pituitary carcinoma.
Topics: Aged; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Bromocriptine; Cabergoline; Combined Modality Therapy; Dacarbazine; Drug Substitution; Ergolines; Fatal Outcome; Headache; Humans; Hyperprolactinemia; Liver Neoplasms; Male; Neoplasm Recurrence, Local; Pituitary Neoplasms; Prolactin; Prolactinoma; Proton Therapy; Temozolomide | 2017 |
Low levels of PRB3 mRNA are associated with dopamine-agonist resistance and tumor recurrence in prolactinomas.
Topics: Adolescent; Adult; Base Sequence; Bromocriptine; Chi-Square Distribution; Dopamine Agonists; Eye Proteins; Female; Gene Expression Regulation, Neoplastic; Humans; Male; Middle Aged; Mucins; Neoplasm Recurrence, Local; Pituitary Neoplasms; Prolactinoma; Proteins; RNA, Messenger; Salivary Proline-Rich Proteins; Young Adult | 2014 |
Withdrawal of dopamine agonist therapy in prolactinomas: In which patients and when?
Topics: Adolescent; Adult; Aged; Bromocriptine; Cabergoline; Deprescriptions; Dopamine Agonists; Ergolines; Female; Humans; Hyperprolactinemia; Male; Middle Aged; Neoplasm Recurrence, Local; Patient Selection; Pituitary Neoplasms; Prolactin; Prolactinoma; Retrospective Studies; Time Factors; Tumor Burden; Young Adult | 2016 |
Prolactinoma presenting as painful postganglionic Horner syndrome.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain; Bromocriptine; Cabergoline; Carotid Arteries; Dopamine Agonists; Ergolines; Horner Syndrome; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Migraine Disorders; Neoplasm Recurrence, Local; p-Hydroxyamphetamine; Pituitary Neoplasms; Prolactin; Prolactinoma; Remission Induction | 2004 |
Rapid re-enlargement of a macroprolactinoma after initial shrinkage in a young woman treated with bromocriptine.
Topics: Adult; Bromocriptine; Combined Modality Therapy; Diagnosis, Differential; Female; Hormone Antagonists; Humans; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Pituitary Neoplasms; Prolactin; Prolactinoma | 2005 |
Repeated transsphenoidal surgery to treat recurrent or residual pituitary adenoma.
Topics: Adenoma; Adolescent; Adult; Aged; Aged, 80 and over; Bromocriptine; Child; Combined Modality Therapy; Female; Hormone Antagonists; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual; Neurosurgical Procedures; Pituitary ACTH Hypersecretion; Pituitary Neoplasms; Postoperative Complications; Predictive Value of Tests; Radiotherapy; Reoperation; Retrospective Studies; Sphenoid Bone; Treatment Outcome | 2005 |
Immunotherapy of prolactinoma with a T helper 1 activator adjuvant and autoantigens: a case report.
Topics: Adjuvants, Immunologic; Adult; Autoantigens; Bromocriptine; Female; Hormone Antagonists; Humans; Immunotherapy; Lymphocyte Activation; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Pituitary Neoplasms; Prolactin; Prolactinoma; Th1 Cells | 2006 |
Rapid resolution of visual field defects and reduction in macroprolactinoma size with bromocriptine therapy. A case report.
Topics: Adenoma, Chromophobe; Adult; Bromocriptine; Female; Humans; Neoplasm Recurrence, Local; Pituitary Neoplasms; Prolactin; Vision Disorders | 1982 |
[Bromocriptine induced cystic tumour regression in advanced prolactinomas (author's transl)].
Topics: Adult; Aged; Bromocriptine; Humans; In Vitro Techniques; Male; Middle Aged; Neoplasm Recurrence, Local; Pituitary Neoplasms; Prolactin; Time Factors | 1981 |
Bromocriptine therapy for "nonfunctioning" pituitary tumors.
Topics: Adenoma, Chromophobe; Bromocriptine; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Pituitary Hormones; Pituitary Neoplasms | 1981 |
Pituitary adenomas in childhood and adolescence.
Topics: Adenoma; Adolescent; Bromocriptine; Child; Female; Fertility; Humans; Immunohistochemistry; Male; Neoplasm Recurrence, Local; Pituitary Neoplasms; Staining and Labeling; Treatment Outcome | 1994 |
[Hyperprolactinemia: importance of early therapy].
Topics: Adenoma; Adult; beta-Endorphin; Bromocriptine; Cushing Syndrome; Female; Humans; Hyperprolactinemia; Neoplasm Recurrence, Local; Pituitary Neoplasms; Time Factors | 1994 |
[Non-puerperal mastitis in real time and color Doppler ultrasound].
Topics: Abscess; Adenocarcinoma; Adolescent; Adult; Aged; Blood Flow Velocity; Breast; Breast Neoplasms; Bromocriptine; Combined Modality Therapy; Diagnosis, Differential; Female; Fibrocystic Breast Disease; Humans; Mastectomy, Segmental; Mastitis; Middle Aged; Neoplasm Recurrence, Local; Ultrasonography, Mammary | 1994 |
Malignant growth of a recurrent macroprolactinoma after radiation therapy.
Topics: Bromocriptine; Cell Transformation, Neoplastic; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Lisuride; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Radiation-Induced; Pituitary Irradiation; Pituitary Neoplasms; Prolactin; Prolactinoma; Tomography, X-Ray Computed | 1993 |
Transsphenoidal pituitary resection for preoperative diagnosis of prolactin-secreting pituitary adenoma in women: long term follow-up.
Topics: Adolescent; Adult; Aged; Amenorrhea; Bromocriptine; Female; Follow-Up Studies; Growth Hormone; Humans; Middle Aged; Neoplasm Recurrence, Local; Pituitary Gland; Pituitary Neoplasms; Pregnancy; Pregnancy Outcome; Prolactinoma; Reoperation | 1996 |
Management of prolactinomas.
Topics: Bromocriptine; Dopamine Agonists; Female; Humans; Male; Neoplasm Recurrence, Local; Pituitary Neoplasms; Prolactinoma | 1997 |
Transformation of a human mixed GH-PRL adenoma cell population in response to long-term bromocriptine treatment.
Topics: Adenoma; Bromocriptine; Child; Child, Preschool; Culture Techniques; Female; Hormone Antagonists; Human Growth Hormone; Humans; Neoplasm Recurrence, Local; Pituitary Neoplasms; Prolactin | 1997 |
Shock syndrome induced by bromocriptine test in a patient with prolactinoma--case report.
Topics: Aged; Bromocriptine; Humans; Male; Neoplasm Recurrence, Local; Pituitary Neoplasms; Prolactinoma; Shock; Syndrome; Vasodilator Agents | 1998 |
Rapid enlargement and recurrence of a preexisting intrasellar craniopharyngioma during the course of two pregnancies. Case report.
Topics: Adult; Bromocriptine; Craniopharyngioma; Diagnosis, Differential; Disease Progression; Female; Follow-Up Studies; Hormone Antagonists; Humans; Neoplasm Recurrence, Local; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactinoma; Sphenoid Bone | 1999 |
Pituitary adenomas in childhood and adolescence. Clinical analysis of 10 cases.
Topics: Acromegaly; Adenoma; Adolescent; Amenorrhea; Bromocriptine; Cabergoline; Child; Ergolines; Female; Headache; Human Growth Hormone; Humans; Male; Neoplasm Recurrence, Local; Octreotide; Pituitary Neoplasms; Prolactinoma; Puberty, Delayed; Radiotherapy; Treatment Outcome; Vision Disorders; Visual Fields | 2001 |
Regression of pituitary prolactinoma after treatment with bromocriptine.
Topics: Adenoma, Chromophobe; Bromocriptine; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Paraneoplastic Endocrine Syndromes; Pituitary Neoplasms; Prolactin; Remission, Spontaneous | 1979 |
Prolactin secreting pituitary carcinoma.
Topics: Adult; Brain; Bromocriptine; Combined Modality Therapy; Humans; Hypophysectomy; Male; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Pituitary Irradiation; Pituitary Neoplasms; Prolactin; Prolactinoma | 1992 |
Positron emission tomography of pituitary macroadenomas: hormone production and effects of therapies.
Topics: Adenoma; Adult; Aged; Antineoplastic Agents; Bromocriptine; Combined Modality Therapy; Energy Metabolism; Female; Glucose; Hormones; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Octreotide; Pituitary Neoplasms; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 1991 |
Metastasis of an occult gastric carcinoma suggesting growth of a prolactinoma during bromocriptine therapy: a case report with a review of the literature.
Topics: Adenocarcinoma, Mucinous; Adenoma; Aged; Bromocriptine; Female; Humans; Hypophysectomy; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Pituitary Gland; Pituitary Neoplasms; Postoperative Complications; Prolactin; Stomach Neoplasms | 1985 |
Transsphenoidal surgery following unsuccessful prior therapy. An assessment of benefits and risks in 158 patients.
Topics: Adenoma; Adrenocorticotropic Hormone; Adult; Bromocriptine; Cerebrospinal Fluid Rhinorrhea; Chordoma; Combined Modality Therapy; Craniopharyngioma; Craniotomy; Female; Humans; Male; Neoplasm Recurrence, Local; Pituitary Diseases; Pituitary Neoplasms; Postoperative Complications; Prolactin; Reoperation; Retrospective Studies; Risk; Sphenoid Bone | 1985 |
Management of prolactinomas associated with very high serum prolactin levels.
Topics: Adenoma; Adolescent; Adult; Aged; Bromocriptine; Combined Modality Therapy; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Pituitary Neoplasms; Prolactin; Retrospective Studies; Tomography, X-Ray Computed | 1988 |
[Follow-up of a pediatric prolactin-producing hypophyseal tumor].
Topics: Adenoma; Adolescent; Bromocriptine; Child; Combined Modality Therapy; Follow-Up Studies; Humans; Male; Neoplasm Recurrence, Local; Pituitary Neoplasms; Prolactin; Tomography, X-Ray Computed | 1986 |
Treatment of recurrent carcinoma of the cervix with bromocriptine.
Topics: Adult; Aged; Bromocriptine; Carcinoma, Squamous Cell; Female; Fluorouracil; Humans; Middle Aged; Neoplasm Recurrence, Local; Uterine Cervical Neoplasms | 1986 |
[Bromocriptine treatment of hyperprolactinemia].
Topics: Adenoma; Adult; Amenorrhea; Bromocriptine; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Pituitary Neoplasms; Pregnancy; Prolactin; Tomography, X-Ray Computed | 1985 |
[Results of bromocriptine treatment of giant or invasive prolactin adenomas. Apropos of 20 cases].
Topics: Adenoma; Adolescent; Adult; Bromocriptine; Female; Humans; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Pituitary Neoplasms; Prolactin; Time Factors | 1985 |